Therapy of thalidomide combined with dexamethasone in patients with proliferative glomerulonephritis with monoclonal IgG deposits

zhou wei,li juan,huang xianghua,ceng caihong,hu weixin,chen chaohong,liu zhihong,cheng zhen

DOI: https://doi.org/10.3969/j.issn.1006-298X.2018.02.001

2018-01-01

Abstract:Objective: To evaluate the efficacy and safety of thalidomide combined with dexamethasone( TD) in patients with proliferative glomerulonephritis with monoclonal Ig G deposits( PGNMID). Methodology: Forty four patients diagnosed as PGNMID from December 2011 to November 2017 were enrolled into this retrospective study. According to with or without TD therapy,they were divided into two groups: TD group( n = 12),and non-TD group( n = 32). Their clinical data,treatment efficacy and safety were analyzed. Chi square test was used to compare the difference between the two remission rates. Results: They were 4 males and 8 females with a median age of 48. 5( 27 ~ 63) years taking the regimen of TD. With a mean follow-up of 7. 5 months,6( 50%) patients achieve renal response,includes 2( 16. 7%) patients achieving complete response and 4( 33. 3%) patients achieving partial response,median time of response was 5. 5 months.5( 83. 3%) patients got hematological response,in which one( 16. 7%) patients obtained complete response,2( 33. 3%)patients obtain very good partial response and 2( 33. 3%) patients obtained partial response. After treatment,serum albumin was significantly improved( P = 0. 002),serum creatinine kept stable( P = 0. 79),urine protein decreased( P =0. 099),and no patient progressed to ESRD. Compared with the TD group,the mean follow-up time of non-TD group was19 months. In this group,5( 15. 63%) patients achieve renal response,including 3( 9. 38%) patients achieving complete response and 2( 6. 25%) patients achieving partial response. The renal response rate was lower than those in TD group( P =0. 045). Three patients got hematological response. Serum creatinine in the last follow-up were worse than the baseline( P =0. 046),albumin( P = 0. 005) and proteinuria( P = 0. 044) were improved,and 9( 28. 1%) patients progressed to ESRD.The common side effects of TD group were mainly numbness( 50%),edema( 50%),sleepiness( 50),and skin lesions( 33%),but most of the patients were tolerable through symptomatic treatment and drug reduction. Conclusion: The TD regiment was effective for our patients with PGNMID. Side effects were common but most of the patients could tolerate it.The long-term effect needs further study.